Clinical trial
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
NCT05318196 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 5, 2022
- Completion date
- September 1, 2032
- Enrollment
- 5,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, cancer, chronic kidney diseases, immune diseases, metabolic disease, solid-organ transplantation